Eli Lilly and Company - LLY
About Gravity Analytica
Recent News
- 10.30.2025 - Q3 2025 Earnings Call
- 10.30.2025 - Q3 2025 Earnings Call
- 09.26.2025 - Lilly opens newest Gateway Labs site in San Diego to boost local biotechnology ecosystem
- 09.26.2025 - Lilly opens newest Gateway Labs site in San Diego to boost local biotechnology ecosystem
- 09.25.2025 - Lilly's Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease
- 09.25.2025 - Lilly's Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease
- 09.25.2025 - U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
- 09.25.2025 - U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
- 09.25.2025 - Bernstein's 2nd Annual Healthcare Forum
- 09.25.2025 - Bernstein's 2nd Annual Healthcare Forum